4 completed, 1 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow blosozumab: new trials by email Literature Review of blosozumab trials Research Report on blosozumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women Blosozumab, Placebo - Osteoporosis, Postmenopausal | Phase 1 | Terminated | Eli Lilly and Company | 28 | 2015-01-01 | 2019-01-22 |
| A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants Blosozumab - Osteoporosis, Postmenopausal | Phase 1 | Completed | Eli Lilly and Company | 15 | 2014-04-01 | 2018-07-16 |
| A Study of LY2541546 in Women With Low Bone Mineral Density LY2541546, Placebo - Osteoporosis | Phase 2 | Completed | Eli Lilly and Company | 154 | 2010-08-01 | 2019-09-17 |
| A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women LY2541546 - SC, LY2541546 - IV, Placebo - SC - Healthy | Phase 1 | Completed | Eli Lilly and Company | 59 | 2009-09-01 | 2018-07-18 |
| A Study of LY2541546 in Healthy Postmenopausal Women LY2541546 - IV, LY2541546 - SC, Placebo - Healthy | Phase 1 | Completed | Eli Lilly and Company | 60 | 2008-06-01 | 2019-01-23 |
Osteoporosis, Postmenopausal (2) · Osteoporosis (1)
United States (5) · Denmark (1) · Estonia (1) · Japan (1) · Lithuania (1)